|
Description: Hematech is developing a large-scale bovine production system that will enable the company to rapidly produce fully-human polyclonal antibodies. These antibodies have a wide variety of therapeutic applications - including immune deficiency, infectious dis
|
|
| |
| Hematech, LLC (South Dakota) |
$3,000 |
|
For-Profit |
Sioux Falls,
SD
|
|
|
Citation
|
|
Source:
Appropriations Report Language - Conference
|
|
Reference:
108-622
|
|
Location:
Line 33, Page 345
|
Citation Excerpt: Polyclonal Human Antibody Production System
|
|